USANA Health Sciences (USNA) Misses Q4 EPS by 1c, Revenues Miss; Offers FY EPS/Revenue Guidance Above Consensus
Get Alerts USNA Hot Sheet
EPS Growth %: -33.7%
Financial Fact:
Interest expense: -46K
Today's EPS Names:
UXIN, TOWN, NRIM, More
Join SI Premium – FREE
USANA Health Sciences (NYSE: USNA) reported Q4 EPS of $1.32, $0.01 worse than the analyst estimate of $1.33. Revenue for the quarter came in at $299 million versus the consensus estimate of $307.69 million.
“USANA finished the year with another quarter of solid results, bolstered by our annual China National Sales Meeting in Macau and a few targeted product promotions in select markets,” said Kevin Guest, Chief Executive Officer.
GUIDANCE:
USANA Health Sciences sees FY2019 EPS of $5.25-$5.55, versus the consensus of $5.12. USANA Health Sciences sees FY2019 revenue of $1.25-1.3 billion, versus the consensus of $1.2 billion.
For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- STMicroelectronics N.V. (STM) Misses Q1 EPS by 9c; offers Q2 outlook
- TRI Pointe Group (TPH) Tops Q1 EPS by 28c, provides outlook
Create E-mail Alert Related Categories
Corporate News, Earnings, Guidance, Hot Guidance, Management CommentsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!